Literature DB >> 23880583

Norovirus variant GII.4/Sydney/2012, Bangladesh.

Mustafizur Rahman, Shamsun Nahar, Mokibul Hassan Afrad, Abu S G Faruque, Tasnim Azim.   

Abstract

Entities:  

Keywords:  Bangladesh; GII.4/Sydney/2012; diarrhea; enteric infections; foodborne infections; gastroenteritis; norovirus; viruses; waterborne infections

Mesh:

Year:  2013        PMID: 23880583      PMCID: PMC3739531          DOI: 10.3201/eid1908.130227

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Noroviruses (NoVs) are the most common cause of foodborne and waterborne outbreaks of gastroenteritis in persons from all age groups in industrialized and developing countries (). Although NoV outbreaks occur throughout the year, activity increases in the winter months, especially in the countries with a temperate climate. As expected, during the last few months of 2012, outbreaks of NoV gastroenteritis markedly increased in Europe and the United States (–). These increases corresponded with the emergence of a variant of genotype GII.4, Sydney/2012, which was first reported from Australia in March 2012 and, subsequently, in the United States, Belgium, Denmark, Scotland, and Japan (,–). We identified the NoV GII.4 variant Sydney/2012 through hospital surveillance on diarrhea etiology in Bangladesh in December 2011 and then throughout 2012. These strains came from 3 hospitals in Dhaka, Matlab, and Mirzapur, where ≈150,000 patients with diarrhea are treated annually. We randomly selected 795 fecal specimens from patients of all ages who sought treatment for diarrhea in these hospitals during 2010–2012 and detected NoV RNA in 90 (33.6%), 72 (27.9%), and 92 (34.2%) samples in 2010, 2011, and 2012, respectively, by performing real-time PCR (). For characterization, we amplified and sequenced 108 samples on the basis of the capsid genes (). Ages of diarrhea patients with NoV infection ranged from 1 month to 91 years (median 15 months; mean 11.9 years). Most (66%) NoV-positive patients were <5 years of age. Infection rates were lowest in patients <3 months (2.1%) and 5–18 years (2.5%) of age. A high number of NoV infections were recorded in adults (28.8% in patients >18 years of age). NoVs were detected throughout the year, and no clear seasonal peaks were observed. Overall, GII was the most predominant genogroup (66.1%), followed by GI (18.1%) and GIV (3.9%). Mixed infections were detected in 11.8% of samples. We observed a high diversity in the GII genogroup and identified at least 11 different genotypes within the group, in which GII.4 constituted 30.1% of all GII strains. Until December 2011, the GII.4 variant NewOrleans/2009 was the most predominant strain (Figure). However, the new GII.4 variant, Sydney/2012, replaced the old variant and appeared as the dominant strain in 2012. We constructed a phylogenetic tree on the basis of 1,026 bases around the junction region of pol and cap genes, and it revealed that the newly identified variant has evolved from previous NoV GII.4 variants Apeldoorn/2007 and NewOrleans/2009 (data not shown).
Figure

Distribution of 108 norovirus (NoV) genotypes in Bangladesh, 2010–2012. Bar chart shows the percentage of NoV genotypes. Mixed genotypes comprise NoV GI and GII. GI comprises GI.1, GI.3, GI.4, GI.5, and GI.9. GII.others comprises GII.2, GII.3, GII.4, GII.6, GII.10, GII.13, GII.16, GII.17, and GII.21.

Distribution of 108 norovirus (NoV) genotypes in Bangladesh, 2010–2012. Bar chart shows the percentage of NoV genotypes. Mixed genotypes comprise NoV GI and GII. GI comprises GI.1, GI.3, GI.4, GI.5, and GI.9. GII.others comprises GII.2, GII.3, GII.4, GII.6, GII.10, GII.13, GII.16, GII.17, and GII.21. NoVs, old and new, remain a substantial threat to human health, with a new variant emerging every 2–3 years. The Sydney/2012 strain appears to have replaced the previously predominant strain, but its clinical effects and epidemiology are largely unknown and warrant further investigation.
  6 in total

1.  Detection of a novel intergenogroup recombinant Norovirus from Kolkata, India.

Authors:  Mukti K Nayak; Ganesh Balasubramanian; Ganesh C Sahoo; Rittwika Bhattacharya; Jan Vinje; Nobumichi Kobayashi; Mamta Chawla Sarkar; Mihir K Bhattacharya; Triveni Krishnan
Journal:  Virology       Date:  2008-07-20       Impact factor: 3.616

2.  Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012.

Authors:  J van Beek; K Ambert-Balay; N Botteldoorn; J S Eden; J Fonager; J Hewitt; N Iritani; A Kroneman; H Vennema; J Vinjé; P A White; M Koopmans
Journal:  Euro Surveill       Date:  2013-01-03

3.  Rapid emergence and antigenic diversification of the norovirus 2012 Sydney variant in Denmark, October to December, 2012.

Authors:  J Fonager; L S Hindbæk; T K Fischer
Journal:  Euro Surveill       Date:  2013-02-28

4.  Use of TaqMan real-time reverse transcription-PCR for rapid detection, quantification, and typing of norovirus.

Authors:  A Angelica Trujillo; Karen A McCaustland; Du-Ping Zheng; Leslie A Hadley; George Vaughn; Susan M Adams; Tamie Ando; Roger I Glass; Stephan S Monroe
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

5.  Increased norovirus activity in Scotland in 2012 is associated with the emergence of a new norovirus GII.4 variant.

Authors:  S Bennett; A MacLean; R S Miller; C Aitken; R N Gunson
Journal:  Euro Surveill       Date:  2013-01-10

6.  Emergence of new norovirus strain GII.4 Sydney--United States, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-01-25       Impact factor: 17.586

  6 in total
  9 in total

1.  The emergence and evolution of the novel epidemic norovirus GII.4 variant Sydney 2012.

Authors:  John-Sebastian Eden; Joanne Hewitt; Kun Lee Lim; Maciej F Boni; Juan Merif; Gail Greening; Rodney M Ratcliff; Edward C Holmes; Mark M Tanaka; William D Rawlinson; Peter A White
Journal:  Virology       Date:  2013-12-25       Impact factor: 3.616

2.  Epidemiology and molecular characteristics of norovirus GII.4 Sydney outbreaks in Taiwan, January 2012-December 2013.

Authors:  Fang-Tzy Wu; Hsieh-Cheng Chen; Catherine Yen; Ching-Yi Wu; Kazuhiko Katayama; YoungBin Park; Aron J Hall; Jan Vinjé; Jason C Huang; Ho-Sheng Wu
Journal:  J Med Virol       Date:  2015-05-06       Impact factor: 2.327

3.  Prevalence and genetic diversity of norovirus genogroup II in children less than 5 years of age with acute gastroenteritis in Tehran, Iran.

Authors:  Mahsa Farsi; Fatemeh Roodbari; Behrooz Nejati; Arash Arashkia; Somayeh Jalilvand; Alireza Nateghian; Aliakbar Rahbarimanesh; Sayed Mahdi Marashi; Zabihollah Shoja
Journal:  Med Microbiol Immunol       Date:  2018-04-04       Impact factor: 3.402

4.  Hospital-based Surveillance for Pediatric Norovirus Gastroenteritis in Bangladesh, 2012-2016.

Authors:  Syed M Satter; Zarin Abdullah; Cristina V Cardemil; Meerjady S Flora; Emily S Gurley; Mahmudur Rahman; Muhammad Talha; Md D Islam; Mohammad E Hossain; Neha Balachandran; Benjamin Lopman; Mustafizur Rahman; Jan Vinjé; Aron J Hall; Umesh D Parashar
Journal:  Pediatr Infect Dis J       Date:  2021-03-01       Impact factor: 3.806

5.  Clinical and epidemiological characteristics of norovirus gastroenteritis among hospitalized children in Lebanon.

Authors:  Nada M Melhem; Hassan Zaraket; Khalil Kreidieh; Zeinab Ali; Moza Hammadi; Soha Ghanem; Farah Hajar; Amjad Haidar; Adlette Inati; Mariam Rajab; Hassan Fakhouri; Bassam Ghanem; Ghassan Baasiri; Ghassan Dbaibo
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742

Review 6.  Norovirus Infections and Disease in Lower-MiddleandLow-Income Countries, 1997⁻2018.

Authors:  Janet Mans
Journal:  Viruses       Date:  2019-04-10       Impact factor: 5.048

7.  Novel norovirus recombinants detected in South Africa.

Authors:  Janet Mans; Tanya Y Murray; Maureen B Taylor
Journal:  Virol J       Date:  2014-09-17       Impact factor: 4.099

8.  Comparative Evaluation of Real-Time PCR Methods for Human Noroviruses in Wastewater and Human Stool.

Authors:  Yoshifumi Masago; Yoshimitsu Konta; Shinobu Kazama; Manami Inaba; Toshifumi Imagawa; Kentaro Tohma; Mayuko Saito; Akira Suzuki; Hitoshi Oshitani; Tatsuo Omura
Journal:  PLoS One       Date:  2016-08-15       Impact factor: 3.240

9.  Molecular epidemiology and temporal evolution of norovirus associated with acute gastroenteritis in Amazonas state, Brazil.

Authors:  Juliana Merces Hernandez; Luciana Damascena Silva; Edivaldo Costa Sousa Junior; Renato Silva Bandeira; Elmer Abraão Martins Rodrigues; Maria Silvia Souza Lucena; Samya Thalita Picanço Costa; Yvone Benchimol Gabbay
Journal:  BMC Infect Dis       Date:  2018-04-02       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.